TrialAlzheimer's research & therapy2024

A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease.

Douglas Galasko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.